Melola Discovery

← Melola Discovery

Jurnal

BREAST CANCER CHEMOTHERAPY RESPONSE IN WAHIDIN SUDIROHUSODO HOSPITAL, MAKASSAR

Nusantara Medical Science Journal · Vol. ume No. 1 (2016) · pp. 1–9

DOI
10.20956/nmsj.v0i1.2202
ISSN
2597-7288, 2460-9757
Published
2016-03-17
Publisher
Faculty of Medicine, Hasanuddin University.
Language
en

Abstract

ABSTRACTIntroduction: Treatments of breast cancer are multidisciplinary. Chemotherapy isone of the most important modalities and has become the standard of breast cancertreatment of in the adjuvant or neoadjuvant setting. Evaluation is needed in order tounderstand the effectivity of the chemotherapy regiment, to improve the servicesystem and to share with other centers. Objectives: to understand thecharacteristics of chemotherapy patients, types of regimen, settings chemotherapyand neoadjuvant chemotherapy response of breast cancer. Methods: Aretrospective study was done by reviewing the administrative data of cancer patientswho were treated in the surgical oncology Wahidin Sudirohusodo Hospital, Makassarin 2014. Results: During 2014 has been carried out chemotherapy for 247 breastcancer patients, used as neoadjuvan setting 145 cases (59 %) and Adjuvan 102cases (41%). The regimen used are CAF 155 cases ( 63%), TAC 55 cases ( 22%), TA 20 cases (8%), GC 11 cases ( 5%), dan Vinoralbine 6 cases (2%).Cumulative Clinical Response are: complete response 3 cases (2%), partialresponse 112 cases (78%), stable disease 23 cases (15%), and progresive disease9 (5%). Chemoterapy response by subtype: Luminal 67%, Her2 70%, Triple Negatif88%. Conclusions: Breast cancer clinical response to various chemotherapyregimens are good, regimen and subtype affect the response to chemotherapy.Keywords: breast cancer, chemotherapy, clinical response

Collaboration network of the authors

16 authors · 42 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Sumin SuminAffiliation unknown1
Khairawati KhairawatiAffiliation unknown1
Aussie Fitriani GhaznawieAffiliation unknown1
Andi Alfian ZainuddinAffiliation unknown1
Akhtar Fajar MuzakkirAffiliation unknown1
F. FathlinaAffiliation unknown1
Ali Aspar MappahyaAffiliation unknown1
Abdul Hakim AlkatiriAffiliation unknown1
Djonny FeriantoAffiliation unknown1
Salman Ardi SyamsuAffiliation unknown1
John Pieter JrAffiliation unknown1
William HamdaniAffiliation unknown1
Erwin A. PatabangAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://journal.unhas.ac.id/index.php/jmednus/oai, first harvested 5 Nov 2026, last seen 5 Nov 2026.
Original metadata (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">BREAST CANCER CHEMOTHERAPY RESPONSE IN WAHIDIN SUDIROHUSODO HOSPITAL, MAKASSAR</dc:title>
	<dc:creator xml:lang="en">Prihantono, Prihantono</dc:creator>
	<dc:creator xml:lang="en">Haryasena, Haryasena</dc:creator>
	<dc:creator xml:lang="en">Sampepajung, Daniel</dc:creator>
	<dc:description xml:lang="en">ABSTRACTIntroduction: Treatments of breast cancer are multidisciplinary. Chemotherapy isone of the most important modalities and has become the standard of breast cancertreatment of in the adjuvant or neoadjuvant setting. Evaluation is needed in order tounderstand the effectivity of the chemotherapy regiment, to improve the servicesystem and to share with other centers. Objectives: to understand thecharacteristics of chemotherapy patients, types of regimen, settings chemotherapyand neoadjuvant chemotherapy response of breast cancer. Methods: Aretrospective study was done by reviewing the administrative data of cancer patientswho were treated in the surgical oncology Wahidin Sudirohusodo Hospital, Makassarin 2014. Results: During 2014 has been carried out chemotherapy for 247 breastcancer patients, used as neoadjuvan setting 145 cases (59 %) and Adjuvan 102cases (41%). The regimen used are CAF 155 cases ( 63%), TAC 55 cases ( 22%), TA 20 cases (8%), GC 11 cases ( 5%), dan Vinoralbine 6 cases (2%).Cumulative Clinical Response are: complete response 3 cases (2%), partialresponse 112 cases (78%), stable disease 23 cases (15%), and progresive disease9 (5%). Chemoterapy response by subtype: Luminal 67%, Her2 70%, Triple Negatif88%. Conclusions: Breast cancer clinical response to various chemotherapyregimens are good, regimen and subtype affect the response to chemotherapy.Keywords: breast cancer, chemotherapy, clinical response</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Hasanuddin University.</dc:publisher>
	<dc:date>2016-03-17</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unhas.ac.id/index.php/jmednus/article/view/2202</dc:identifier>
	<dc:identifier>10.20956/nmsj.v0i1.2202</dc:identifier>
	<dc:source xml:lang="en">Nusantara Medical Science Journal; Volume I No. 1 Januari-Maret 2016; 1-9</dc:source>
	<dc:source>2597-7288</dc:source>
	<dc:source>2460-9757</dc:source>
	<dc:source>10.20956/nmsj.v0i1</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://journal.unhas.ac.id/index.php/jmednus/article/view/2202/1222</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2017 Nusantara Medical Science Journal</dc:rights>
</oai_dc:dc>